Stay updated on FGF401 in HCC and Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the FGF401 in HCC and Solid Tumors Clinical Trial page.

Latest updates to the FGF401 in HCC and Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedResources were updated to include Hepatocellular carcinoma and the Genetic and Rare Diseases Information Center, and the page revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision history updated to v3.4.3; v3.4.2 was removed.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedPage layout and navigation appear updated; no core study data (eligibility criteria, endpoints, locations, or results) is visibly changed.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page now displays Revision: v3.4.2, replacing Revision: v3.4.1.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1. This appears to be a minor update to the page's backend or formatting and does not change study details or content.SummaryDifference0.0%

- Check56 days agoChange DetectedAdded a Show glossary toggle and updated minor footer text (Last Update Submitted that Met QC Criteria; No FEAR Act Data) and changed the Revision from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to FGF401 in HCC and Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FGF401 in HCC and Solid Tumors Clinical Trial page.